XML 53 R42.htm IDEA: XBRL DOCUMENT

OPERATING SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2024

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income


		December 31, 2023

		2023 Reported										Fixed				2023 Reported
		Valued at 2023									Currency					Valued at 2024
(millions)		Management Rates				Other					Rate Change					Management Rates
Net Sales
Global Industrial			$7,193.1				$407.3					$40.1					$7,640.5
Global Institutional & Specialty			4,994.0				-					20.6					5,014.6
Global Healthcare & Life Sciences			1,576.9				-					30.6					1,607.5
Global Pest Elimination			-				1,061.5					8.7					1,070.2
Other			1,442.3				(1,442.3)					-					-
Corporate			69.1				(26.5)					0.1					42.7
Subtotal at fixed currency rates			15,275.4				-					100.1					15,375.5
Effect of foreign currency translation			44.8									(100.1)					(55.3)
Consolidated reported GAAP net sales			$15,320.2				$-					$-					$15,320.2

Operating Income
Global Industrial			$1,080.7				$39.0					$2.3					$1,122.0
Global Institutional & Specialty			823.0				14.9					3.9					841.8
Global Healthcare & Life Sciences			160.0				(6.7)					7.5					160.8
Global Pest Elimination			-				209.0					1.4					210.4
Other			255.0				(255.0)					-					-
Corporate			(331.7)				(1.2)					0.1					(332.8)
Subtotal at fixed currency rates			1,987.0				-					15.2					2,002.2
Effect of foreign currency translation			5.3				-					(15.2)					(9.9)
Consolidated reported GAAP operating income			$1,992.3				$-					$-					$1,992.3

Schedule of financial information for each of the entity's reportable segments

Second Quarter Ended

Six Months Ended

June 30

June 30

(millions)

2024

2023

2024

2023

Net Sales

Global Industrial

$1,956.0

$1,906.4

$3,797.7

$3,714.6

Global Institutional & Specialty

1,372.7

1,273.7

2,643.0

2,404.9

Global Healthcare & Life Sciences

395.0

395.3

777.9

781.4

Global Pest Elimination

297.1

269.7

563.9

514.3

Corporate

-

10.6

-

21.3

Subtotal at fixed currency rates

4,020.8

3,855.7

7,782.5

7,436.5

Effect of foreign currency translation

(35.0)

(3.6)

(44.8)

(12.8)

Consolidated reported GAAP net sales

$3,985.8

$3,852.1

$7,737.7

$7,423.7

Operating Income

Global Industrial

$311.9

$264.9

$576.9

$484.7

Global Institutional & Specialty

320.7

213.4

568.7

343.5

Global Healthcare & Life Sciences

33.7

33.2

70.7

68.6

Global Pest Elimination

62.2

52.4

111.0

96.9

Corporate

(62.8)

(79.3)

(142.6)

(156.7)

Subtotal at fixed currency rates

665.7

484.6

1,184.7

837.0

Effect of foreign currency translation

(8.8)

0.1

(9.9)

(0.7)

Consolidated reported GAAP operating income

$656.9

$484.7

$1,174.8

$836.3